Resurfacing is al alternative that has been suggested for use in younger individuals instead of a full hip replacement.  With this recent approval the company can go beyond the prior premarket approval.  I remember just a few years ago resurfacing was not even approved in the US and most have to go overseas to have this procedure done.  Reimbursement and coding can be viewed on the company site here.  BD

Wright Medical Group, Inc. (WMGI) recently received the Food and Drug administration (FDA) approval to market its CONSERVE Plus Total Hip Resurfacing System in the U.S. The new system, which has received FDA approval, provides surgeons with a bone-conserving alternative to traditional total hip replacement.
With the FDA approval, Wright Medical can now market CONSERVE Plus in the original femoral and acetabular component configuration in the U.S. as specified in its PreMarket Approval (PMA) application with the FDA. The company also intends to develop additional enhancements to the system. Wright Medical is already marketing its CONSERVE Plus system, which has received FDA approval, with additional features in the international markets.

Wright Receives FDA Approval

Technorati Tags: FDA,hip resurfacing,hip surgery,hip replacement,heatlhcare,surgery,medical device,technology